EP2219631A1 - Verwendung von antibakteriellen verbindungen mit narkosewirkung - Google Patents

Verwendung von antibakteriellen verbindungen mit narkosewirkung

Info

Publication number
EP2219631A1
EP2219631A1 EP08850320A EP08850320A EP2219631A1 EP 2219631 A1 EP2219631 A1 EP 2219631A1 EP 08850320 A EP08850320 A EP 08850320A EP 08850320 A EP08850320 A EP 08850320A EP 2219631 A1 EP2219631 A1 EP 2219631A1
Authority
EP
European Patent Office
Prior art keywords
amylmetacresol
dichlorobenzyl alcohol
hexetidine
lidocaine
cetylpyridinium chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP08850320A
Other languages
English (en)
French (fr)
Inventor
Adrian Shephard
Michael Stillings
Gertrud Haeseler
Martin Leuwer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38896290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2219631(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Priority to EP20120191946 priority Critical patent/EP2570123A1/de
Publication of EP2219631A1 publication Critical patent/EP2219631A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP08850320A 2007-11-15 2008-11-17 Verwendung von antibakteriellen verbindungen mit narkosewirkung Ceased EP2219631A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP20120191946 EP2570123A1 (de) 2007-11-15 2008-11-17 Verwendung von 2,4-Dichlorbenzylalkohol mit anästhetischer Wirkung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0722349.8A GB0722349D0 (en) 2007-11-15 2007-11-15 Use of anti-bacterial compounds having an anaesthetic effect
PCT/GB2008/003852 WO2009063223A1 (en) 2007-11-15 2008-11-17 Use of anti-bacterial compounds having an anaesthetic effect

Publications (1)

Publication Number Publication Date
EP2219631A1 true EP2219631A1 (de) 2010-08-25

Family

ID=38896290

Family Applications (2)

Application Number Title Priority Date Filing Date
EP20120191946 Ceased EP2570123A1 (de) 2007-11-15 2008-11-17 Verwendung von 2,4-Dichlorbenzylalkohol mit anästhetischer Wirkung
EP08850320A Ceased EP2219631A1 (de) 2007-11-15 2008-11-17 Verwendung von antibakteriellen verbindungen mit narkosewirkung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP20120191946 Ceased EP2570123A1 (de) 2007-11-15 2008-11-17 Verwendung von 2,4-Dichlorbenzylalkohol mit anästhetischer Wirkung

Country Status (11)

Country Link
EP (2) EP2570123A1 (de)
JP (1) JP2011503163A (de)
KR (1) KR101553031B1 (de)
CN (1) CN101854927B (de)
AU (1) AU2008322739C1 (de)
GB (1) GB0722349D0 (de)
MX (1) MX2010005359A (de)
MY (1) MY153768A (de)
RU (1) RU2010123797A (de)
WO (1) WO2009063223A1 (de)
ZA (1) ZA201003410B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9248093B2 (en) 2009-06-11 2016-02-02 Becton, Dickinson And Company Catheter locking solution having antimicrobial and anticoagulation properties
DK2701681T3 (en) 2011-04-29 2017-01-09 Moberg Pharma Ab PHARMACEUTICAL COMPOSITIONS COMPRISING A LOCAL ANESTHETICS as bupivacaine for local administration to the mouth or throat
WO2016126217A1 (en) 2015-02-03 2016-08-11 Pharmacti̇ve Ilaç Sanayi̇ Ve Ti̇caret A. Ş. Stable pharmaceutical combination containing benzydamine
CN117082977A (zh) * 2021-12-31 2023-11-17 振德医疗用品股份有限公司 一种长效抗菌消毒剂及制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1073916A (en) * 1963-11-04 1967-06-28 Boots Pure Drug Co Ltd A new aminoalkanol salt
CA1273576A (en) * 1987-09-16 1990-09-04 Patrick A. Beauchamp Topical treatment for diseased skin disorders
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping
WO2003089007A1 (en) * 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
US20090156563A1 (en) 2005-11-30 2009-06-18 Werner Baschong Glucan Compositions
WO2007110871A2 (en) * 2006-03-29 2007-10-04 Naveh Pharma (1996) Ltd. Methods and composition for treating sore throat

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2009063223A1 *

Also Published As

Publication number Publication date
EP2570123A1 (de) 2013-03-20
AU2008322739A1 (en) 2009-05-22
KR20100097137A (ko) 2010-09-02
JP2011503163A (ja) 2011-01-27
CN101854927A (zh) 2010-10-06
KR101553031B1 (ko) 2015-09-14
RU2010123797A (ru) 2011-12-20
AU2008322739B2 (en) 2014-07-10
GB0722349D0 (en) 2007-12-27
MX2010005359A (es) 2010-08-31
WO2009063223A1 (en) 2009-05-22
MY153768A (en) 2015-03-13
CN101854927B (zh) 2013-09-04
AU2008322739C1 (en) 2018-08-30
ZA201003410B (en) 2011-07-27

Similar Documents

Publication Publication Date Title
De Lepeleire et al. Montelukast causes prolonged, potent leukotriene D4‐receptor antagonism in the airways of patients with asthma
JP4898073B2 (ja) 鼻内投与用フェンタニル組成物
US20090117054A1 (en) Sublingual spray for the treatment of pain
JP2004521111A5 (de)
JP2005506367A5 (de)
AU2010248776A1 (en) Sublingual dexmedetomidine compositions and methods of use thereof
PT999841E (pt) Composicoes farmaceuticas contendo hemissulfato de eletriptano
NO334441B1 (no) Preparat for behandling av vanlig forkjølelse.
ZA200806671B (en) Therapeutic compositions for intranasal administration of ketorolac
KR20220132666A (ko) 지속성 국소 마취용 네오삭시톡신 조합 제형
WO2008073324A1 (en) Topical eutectic anesthetic composition for oral or dermal tissue
AU2008322739B2 (en) Use of anti-bacterial compounds having an anaesthetic effect
Danielsson et al. Long-acting local anaesthetics in oral surgery: clinical evaluation of bupivacaine and etidocaine for mandibular nerve block
US20030130314A1 (en) Analgesic delivery systems and methods of use
BR112019011961A2 (pt) formulação tópica, método para prover tratamento não-sistêmico prolongado para dor em um indivíduo humano necessitando do mesmo, método para formar um depósito subcutâneo de detomidina ou um sal do mesmo em um indivíduo humano, formulação tópica e método para prover o tratamento para dor em um indivíduo humano necessitando do mesmo
WO2002055107A1 (fr) Compositions anesthesiques topiques
US6545057B2 (en) Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics
WO2008138089A2 (en) Pharmaceutical composition comprising a local anaesthetic and a carboxyvinyl polymer
AU2016228287A1 (en) Use of anti-bacterial compounds having an anaesthetic effect
AU2014246589A1 (en) Use of anti-bacterial compounds having an anaesthetic effect
Swapna et al. Pharmacotheurapetics in Prosthodontics-A Review
US11642328B2 (en) Creatine, its derivatives, compositions and methods of use thereof
ES2952672T3 (es) Tratamiento del dolor neuropático asociado a la neuropatía periférica inducida por la quimioterapia
WO2007111933A2 (en) Pharmaceutical compositions comprising a hypoglycemic agent and methods of using same
JP2004525096A (ja) チエニルシクロヘキシルアミン誘導体の新規な医療用途

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100614

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HAESELER, GERTRUD

Inventor name: LEUWER, MARTIN

Inventor name: SHEPHARD, ADRIAN

Inventor name: STILLINGS, MICHAEL

17Q First examination report despatched

Effective date: 20101112

DAX Request for extension of the european patent (deleted)
APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20170214